Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Number and proportion of new registrations of brand and generic anti-infectives from January 2005 to April 2014

From: Trade agreements and drug access: assessment of the impact of the 2009 Peruvian new drug policy on anti-infectives registration and availability

Years Brand Generic Total
n % n % N
2005 311 65.5 164 34.5 475
2006 335 63.4 193 36.6 528
2007 332 65.1 178 34.9 510
2008 451 72.4 172 27.6 623
2009 364 81.3 84 18.8 448
2010 70 76.9 21 23.1 91
2011 45 75.0 15 25.0 60
2012 103 73.6 37 26.4 140
2013 60 75.0 20 25.0 80
2014a 26 74.3 9 25.7 35
  1. aThrough April